Search Results - Estévez, LG

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Abstract P4-03-16: FAPα (fibroblast activation protein-α) analysis in breast tumor cells and stroma after neoadjuvant treatment

    Abstract P4-03-16: FAPα (fibroblast activation protein-α) analysis in breast tumor cells and stroma after neoadjuvant treatment by Calvo, I, Prieto, M, Suárez-Gauthier, A, Pérez, FJ, Hernández, E, Acosta, D, Cárdenas, JM, López-Ríos, F, Estévez, LG

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Abstract P4-15-09: An exploratory analysis of inactivation of PI3K/AKT/mTOR signaling pathway using neoadjuvant BKM120 in PI3KCA mutated early breast cancer

    Abstract P4-15-09: An exploratory analysis of inactivation of PI3K/AKT/mTOR signaling pathway using neoadjuvant BKM120 in PI3KCA mutated early breast cancer by Estevez, LG, Suarez, A, Calvo, I, Fernandez-Abad, M, Perea, S, Hidalgo, M

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Weekly docetaxel as neoadjuvant chemotherapy for stage II and III breast cancer: Efficacy and correlation with biological markers in a phase II, multicenter study

    Weekly docetaxel as neoadjuvant chemotherapy for stage II and III breast cancer: Efficacy and correlation with biological markers in a phase II, multicenter study by ESTEVEZ, Laura G, CUEVAS, José Miguel, ANTON, Antonio, FLORIAN, Jesus, LOPEZ-VEGA, José Manuel, VELASCO, Amalia, LOBO, Francisco, HERRERO, Ana, FORTES, José

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Abstract P5-18-15: Molecular effects of lapatinib in HER2 positive ductal carcinoma in situ (DCIS)

    Abstract P5-18-15: Molecular effects of lapatinib in HER2 positive ductal carcinoma in situ (DCIS) by Estevez, LG, Suarez, A, Calvo, I, Garcia, E, Miro, C, Durán, H, Quijano, Y, Perea, S, Herrero, M, Lopez-Rios, F, Hidalgo, M

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Abstract P2-06-17: Biological Study of the Effects of GW572016 (Lapatinib) in Ras/Raf/MAK and PI3K/Akt Signaling Pathways in HER2 Positive Ductal Breast Carcinoma in Situ (DCIS)

    Abstract P2-06-17: Biological Study of the Effects of GW572016 (Lapatinib) in Ras/Raf/MAK and PI3K/Akt Signaling Pathways in HER2 Positive Ductal Breast Carcinoma in Situ (DCIS) by Estevez, LG, Suarez, A, Calvo, I, Ugidos, L, Miró, C, Durán, H, Quijano, Y, Herrero, M, López-Ríos, F, Hidalgo, M.

    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Phase II study of ifosfamide plus vinorelbine in metastatic breast cancer patients previously treated with combination chemotherapy

    Phase II study of ifosfamide plus vinorelbine in metastatic breast cancer patients previously treated with combination chemotherapy by LOBO, F, FRAU, A, ESTEVEZ, L. G, BARNADAS, A, MENDEZ, M, LIZON, J, PROVENCIO, M, ALBISTUR, J. J, MARTINEZ, P, SANCHEZ, M. J, CONSTENLA, M

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: